Filter
909
Filtered Results: 909
Text search:
medicine
manufacturing
Featured
Recommendations
78
New Publications
217
Language
Document type
No document type
407
Studies & Reports
203
Guidelines
147
Strategic & Response Plan
54
Manuals
50
Fact sheets
24
Situation Updates
9
Training Material
7
Resource Platforms
4
Brochures
2
Infographics
1
Videos
1
Countries / Regions
India
41
Kenya
35
Global
33
Nigeria
24
Uganda
23
Ethiopia
21
Ghana
20
Western and Central Europe
16
South Africa
16
Tanzania
15
Nepal
13
Africa
13
Zambia
13
Sierra Leone
12
Rwanda
12
Bangladesh
12
Lesotho
10
Philippines
10
South–East Asia Region
9
Malawi
8
West and Central Africa
8
East and Southern Africa
8
Liberia
8
Myanmar / Burma
8
Ukraine
7
Syria
7
Zimbabwe
7
Latin America and the Carribbean
7
Namibia
7
Botswana
7
Eastern Europe
5
Indonesia
5
Thailand
4
USA
4
Haiti
4
Cambodia
4
Congo, Democratic Republic of
4
Eswatini/ Swaziland
4
Cameroon
3
Albania
3
Asia
3
Moldova
3
Sri Lanka
3
Russia
3
South Sudan
3
Pakistan
3
Tajikistan
2
Benin
2
China
2
Laos
2
Senegal
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Mauritius
2
United Kingdom
2
Sudan
2
Yemen
2
Serbia
1
Australia
1
Afghanistan
1
Mongolia
1
Jordan
1
Germany
1
Turkmenistan
1
Maldives
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Brazil
1
Egypt
1
Angola
1
Chad
1
Iraq
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
342
Clinical Guidelines
72
Public Health
42
Pharmacy & Technologies
34
Key Resources
31
Women & Child Health
15
Capacity Building
6
Toolboxes
COVID-19
106
Pharmacy
93
AMR
91
HIV
58
Planetary Health
46
TB
36
Mental Health
30
NTDs
25
Rapid Response
23
Global Health Education
17
NCDs
16
Ebola & Marburg
14
Disability
13
Conflict
13
Specific Hazards
10
Caregiver
8
Natural Hazards
7
Health Financing Toolbox
7
Refugee
4
Cholera
3
Zika
1
Polio
1
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Inspection Cooperation Scheme (jointly known as PIC/S)...
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
Control of pollution from antibiotic manufacturing is a key part of safeguarding the longevity of antibiotics for all. Pollution contributes to antibiotic resistance and potentially undermines the effectiveness of medicines. High levels of antibiotics in water bodies downstream of manufacturing site...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
14.04.2016
Pharm -Ed
--
The alcohol-based solution for hand hygiene is now part of the WHO essential medicines list .Local production of the alcohol-based handrub is an alternative to commercial products. Although adapted to contexts with limited resources, it is essential to respect the Good Man...
The National pharmaceutical policy aligns itself to the Government vision for development of the health sector, as defined in Vision 2020, the Millennium Development Goals and the Economic Development for Poverty Reduction Strategy and the National Health Policy. The pharmacy policy addresses, among...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
Doc. No.: INS/GDL/001-(Annexes)
PMPB/INS-GUIDE/02
A.55 Medicines and Related Substances Act, 2013 | No. 8 of 2013 | An Act to provide for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing of medicines and related substances, and matters incidental thereto.
Guidance for the preparation and submission of dossiers
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Prices people pay for medicines.
